0:15 - Meeting Begins
3:10 - Opening Keynote from Namandjé Bumpus, U.S. FDA and Peter Marks, CBER, U.S. FDA
28:42 - The Evolution of Cell and Gene Therapies: Current Advances and Challenges - Presentation by Carl June, University of Pennsylvania
59:41 - Opportunities to Enhance Adoptive T Cell Therapies using CRISPR Gene Editing - Presentation by Alex Marson, Gladstone Institutes
1:23:17 - Session 1 Panel Discussion: Shaping the Future of Cell and Gene Therapies: Challenges & Opportunities
2:51:04 - Leveraging Traceable Heterogeneity in CAR-T Investigational Products in Human Trials - Presentation by Marcela Maus, Massachusetts General Hospital
3:24:01 - Session 2 Panel Discussion: Discovering & Developing the Next Generation of Cell-based Gene Therapies: Considerations for First-in-Human Trials
4:07:48 - Key Takeaways

свернуть